Karyopharm Therapeutics Inc. (KPTI)
KPTI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4274
-15.38% on the day
Market cap
$9.7M
Nano cap
Revenue · 2025
$146.1M
+0.6% on 2024
Net income · 2025
-$196.0M
-134.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | KPTI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2013 |
| SEC CIK | 0001503802 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $146.1M |
| Net income | -$196.0M |
| Operating income | -$90.7M |
| Net margin | -134.2% |
| Operating margin | -62.1% |
| Revenue growth | +0.6% |
| Cash | $60.5M |
| Total assets | $108.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-05-04 |
| Latest annual report | 10-K | 2026-02-13 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEF 14A | 2026-04-13 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc. | $0.2148 | -5.21% | $9.5M |
| TOVX | Theriva Biologics Inc. | $0.2157 | -1.69% | $9.9M |
| MTVA | MetaVia Inc. | $1.43 | -1.38% | $9.4M |
| GDTC | CytoMed Therapeutics Limited | $0.8700 | +7.22% | $10.3M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
| CMMB | Chemomab Therapeutics Ltd. American Depositary Share | $1.24 | -10.79% | $9.0M |
| BFRG | Bullfrog AI Holdings Inc. | $0.5689 | -2.55% | $10.5M |
| MBRX | Moleculin Biotech Inc. | $0.4352 | +5.15% | $8.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier